SAPA believes the wearing of masks by school children could be better managed

SAPA believes the wearing of masks by school children could be better managed

The South African Paediatric Association believes that the issue of wearing of masks by school children could be better managed.

The Association says it supports the use of masks in appropriate and selective circumstances, rather than continuing with its universal use.

Professor Mignon McCulloch from the Red Cross War Memorial Children’s Hospital, weighs in.

Tune into Newzroom Afrika, DSTV channel 405, for more details.

Position Statement: Ambulatory care for children with COVID‐19

Position Statement: Ambulatory care for children with COVID‐19

Summary:

This document has been prepared by the South African Paediatric Association (SAPA) to assist primary  health care workers, general practitioners, and paediatricians in the ambulatory / out-patient / home-based care of children with SARS-CoV-2 infection.

Important considerations  Children with mild COVID-19 can be safely managed in isolation at home. Children with moderate or  severe  COVID-19  require  hospitalisation;  clinical  signs  include:  tachypnoea,  lower  chest  wall  indrawing, <92% oxygen saturation in room air, restlessness, difficulty in completed feeds or speaking  sentences. Not specific to COVID-19, the integrated management of childhood illness general danger  signs for children under 5 years are:

  • inability to drink or breastfeed
  • vomiting without retaining any fluids
  • lethargy or unconsciousness
  • convulsions

In addition, heath care workers need to be mindful of the presence of dehydration, persistent fever  and WHO signs of multisystem inflammatory syndrome in children (MIS-C)*.

There is limited evidence for the use of medication in the management of ambulatory COVID-19 in  children. The following proposed medications have been suggested based on expert opinion and or  extrapolated from adult studies. In general, the ambulatory/home-based management of children  is largely supportive with close monitoring for signs of deterioration.

There is currently no convincing data supporting the use of vitamin A, vitamin C, vitamin D, thiamine, nicotinic acid, zinc, selenium, inhaled steroids or short acting β‐agonist, lopinavir/ritonavir, hydroxychloroquine, azithromycin, ivermectin, cough mixtures or any other medication in children with COVID‐19; their routine use for this indication is consequently discouraged.

Corticosteroids, anticoagulation, antiviral or monoclonal antibody treatment for COVID‐19 or MIS‐C may be used in hospitalised children but are not indicated as part of ambulatory care. The care of people with SARS‐CoV‐2 infection is an area of active research and these recommendations will be updated as required.

SAPA’s Position

This document represents the view of the South African Paediatric Association, a professional society representing paediatricians in the public and private sector in South Africa. The document is supported by the Paediatric Management Group.

*https://www.nicd.ac.za/wp‐content/uploads/2020/09/MIS_C‐Case‐Def_09‐Sept‐2020.pdf

SAPA on ENCA

SAPA on ENCA

The ACDP and some doctors are challenging efforts to vaccinate children aged between 12 and 17 against COVID-19.

Dr Despina Demopoulos is questioned if parents should have any concerns about the jab.

View the full interview below: